Impact of Asian and black donor and recipient ethnicity on the outcomes after deceased donor kidney transplantation in the United Kingdom

Abdul R Hakeem; Sonal Asthana; Rachel J Johnson; Chloe Brown; Niaz Ahmad

doi:10.1101/2021.05.04.21256445

Abstract

Background Patients of Asian and black ethnicity face disadvantage on the renal transplant waiting list in the United Kingdom, because of lack of HLA and blood group matched donors from an overwhelmingly white deceased donor pool. This study evaluates outcomes of renal allografts arising from Asian and black donors.

Methods The UK Transplant Registry was analysed for adult deceased donor kidney only transplants performed during January 2001-December 2015.

Results Asian and black ethnicity patients constituted 12.4% and 6.7% of all deceased donor recipients but only 1.6% and 1.2% of all deceased donors, respectively. Across all recipients, and unsurprisingly given the predominantly white recipient pool, HLA matching was superior for grafts from white donors than from Asian and black donors (p<0.0001). Unadjusted survival analysis demonstrated significantly inferior long-term allograft outcomes associated with Asian and black donors, compared to white donors (7-year graft survival 71.9%, 74.0% and 80.5%; log-rank p=0.0007, respectively). On Cox regression analysis, Asian donor (HR 1.37 for Asian donors vs. white donors as baseline) and black recipient (HR 1.21 for black recipients vs. white recipient as baseline) ethnicities were associated with poorer outcomes than white counterparts, and on ethnicity matching, compared with the white donor–white recipient baseline group and adjusting for other donor and recipient factors, 5-year graft outcomes were significantly poorer for black donor-black [HR 1.92 (1.11-3.32), p=0.02], Asian donor-white recipient [HR 1.56 (1.09-2.24), p=0.016] and white donor-black recipient [HR 1.22 (1.05-1.42), p=0.011] combinations in decreasing order of worse unadjusted 5-year graft survival.

Conclusions Increased deceased donation among ethnic minority communities would benefit the entire recipient pool by increasing the numbers of available organs and may specifically benefit the Asian and black recipients by increasing the numbers of blood group and HLA-compatible grafts for allocation but may not improve allograft outcomes.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

None

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study has been approved by the National Health Service Blood and Transplant (UK Transplant Registry) and anonymous data was provided by the registry to the Study Investigators. The ethical approval for the conduct of this study was granted by the UK Transplant Registry.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

Disclosure: The authors declare no conflicts of interests.
Grants and Financial Support: None
Conflict of Interest: “I, Dr Abdul Rahman Hakeem, the Submitting Author has the right to grant and does grant on behalf of all authors of the Work (as defined in the author licence), an exclusive licence and/or a non-exclusive licence for contributions from authors who are: i) UK Crown employees; ii) where BMJ has agreed a CC-BY licence shall apply, and/or iii) in accordance with the terms applicable for US Federal Government officers or employees acting as part of their official duties; on a worldwide, perpetual, irrevocable, royalty-free basis to BMJ Publishing Group Ltd (“BMJ”) its licensees.
Author contact:
Abdul R Hakeem [abdul.hakeem1{at}nhs.net]
Sonal Asthana [sonal{at}transplantationliver.com]
Rachel Johnson [rachel.johnson{at}nhsbt.nhs.uk]
Chloe Brown [chloe.brown{at}nhsbt.nhs.uk]
Niaz Ahmad [niazahmad{at}hotmail.com]